BANK OF AMERICA CORP /DE/ - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is and the CUSIP is 14757U208. A total of 22 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2112
+300.0%
0.00%
Q3 2022$030.0%0.00%
Q2 2022$030.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 132,014$378,0000.07%
FEDERATED HERMES, INC. 1,015,000$2,903,0000.01%
BAILARD, INC. 31,530$90,0000.00%
RBF Capital, LLC 15,936$46,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 11,686$33,0000.00%
ROYAL BANK OF CANADA 18$00.00%
VANGUARD GROUP INC 306,132$875,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 13$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
DIMENSIONAL FUND ADVISORS LP 13,205$38,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders